NIPRIDE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 05 Jan 2024)
What this means for you
Registered since 11 Jul 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86943618
- Registration number
- 5242417
- Mark type
- Stylized text
- Filed
- 17 Mar 2016
- Published for opposition
- 13 Sept 2016
- Registered
- 11 Jul 2017
- Attorney of record
- Alisa C. Simmons
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of hypertension
Owner
- Exela Innovations, Lenoir, NC, US
- Exela Innovations, Lenoir, NC, US
- Exela Innovations, Lenoir, NC, US
Prosecution history
- 05 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 05 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Jul 2023 — TEAS SECTION 8 & 15 RECEIVED
- 11 Jul 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 06 Jun 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jun 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Jun 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2017 — USE AMENDMENT FILED
- 31 May 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 May 2017 — TEAS STATEMENT OF USE RECEIVED
- 29 Mar 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Mar 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Nov 2016 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT